Equivalence of freeze-dried and liquid-frozen formulations of MVA-BN as smallpox and mpox vaccine
Modified Vaccinia Ankara Bavarian Nordic (MVA-BN) as a smallpox and mpox vaccine has been approved in its liquid-frozen (LF) formulation in the US, Canada, and EU. A freeze-dried (FD) formulation may offer additional benefits, such as a longer shelf life and reduced dependence on cold chain storage...
Saved in:
| Main Authors: | Richard N. Greenberg, Darja Schmidt, Daniela Reichhardt, Siegfried Roesch, Sanja Vidojkovic, Jane Maclennan, Liddy M. Chen, Robert Gruenert, Christian Kreusel, Heinz Weidenthaler, Thomas P.H. Meyer, Paul John Chaplin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2384189 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Rise of Mpox in a Post-Smallpox World
by: Jennifer H. McQuiston, et al.
Published: (2025-01-01) -
Short-Lived Neutralizing Antibody Responses to Monkeypox Virus in Smallpox Vaccine–Naive Persons after JYNNEOS Vaccination
by: Kara Phipps, et al.
Published: (2025-02-01) -
Evolution of means and principles of smallpox vaccination
by: S. V. Borisevich, et al.
Published: (2020-06-01) -
Temporal expression classes and functions of vaccinia virus and mpox (monkeypox) virus genes
by: Yining Deng, et al.
Published: (2025-04-01) -
Tecovirimat in the management of poxviruses: a narrative review of available evidence
by: Olalekan John Okesanya, et al.
Published: (2025-02-01)